Genesco (GCO) Cash & Equivalents (2010 - 2026)

Genesco's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $105.4 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 209.95% year-over-year to $105.4 million; the TTM figure through Jan 2026 stood at $105.4 million (up 209.95% YoY), while the FY2026 annual figure was $105.4 million, up 209.95% from the prior year.
• Cash & Equivalents was $105.4 million for Q1 2026 at Genesco, up from $27.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $320.5 million in Q1 2022 to a low of $19.2 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $66.6 million across 5 years, with a median of $35.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents slumped 88.64% in 2022, then soared 209.95% in 2026.
• A 5-year view of Cash & Equivalents shows it stood at $32.1 million in 2022, then slumped by 32.45% to $21.7 million in 2023, then surged by 54.8% to $33.6 million in 2024, then dropped by 19.49% to $27.0 million in 2025, then surged by 289.9% to $105.4 million in 2026.
• The last three Cash & Equivalents figures came in at $105.4 million (Q1 2026), $27.0 million (Q4 2025), and $41.0 million (Q3 2025), per Business Quant data.